Loading...
Docoh
Log in Free sign up

Haemonetics (HAE)

News

From Benzinga Pro
Morgan Stanley Maintains Equal-Weight on Haemonetics, Lowers Price Target to $60
11 May 22
News, Price Target, Analyst Ratings
Morgan Stanley maintains Haemonetics (NYSE:HAE) with a Equal-Weight and lowers the price target from $64 to $60.
Raymond James Maintains Outperform on Haemonetics, Lowers Price Target to $63
11 May 22
News, Price Target, Analyst Ratings
Raymond James analyst Andrew Cooper maintains Haemonetics (NYSE:HAE) with a Outperform and lowers the price target from $66 to $63.
103 Biggest Movers From Yesterday
11 May 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
77 Stocks Moving In Tuesday's Mid-Day Session
10 May 22
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers
Haemonetics: Q4 Earnings Insights
10 May 22
Earnings, News
Haemonetics (NYSE:HAE) reported its Q4 earnings results on Tuesday, May 10, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Haemonetics Q4 Adj. EPS $0.65 Beats $0.60 Estimate, Sales $265.00M Beat $257.82M Estimate
10 May 22
Earnings, News
Haemonetics (NYSE:HAE) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.60 by 8.33 percent. This is a 41.3 percent increase over earnings of $0.46 per share from the same
Earnings Scheduled For May 10, 2022
10 May 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More
9 May 22
Biotech, Earnings, Mid Cap, News, Penny Stocks, Small Cap, FDA, IPOs, Top Stories, General
Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ: IBB), considered a proxy for the sector, shed close to 3 percent during the week.

Press releases

From Benzinga Pro
Haemonetics to Host Investor Day Event on June 29, 2022
10 May 22
Press Releases
BOSTON, May 10, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that it will host an Investor Day in Boston on Wednesday, June 29, 2022 beginning at 10:00 AM EDT. Members of Haemonetics' leadership
Haemonetics 4th Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website
10 May 22
Earnings, Press Releases
Financial release accessible online BOSTON, May 10, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that financial results for its fourth quarter fiscal 2022, which ended April 2, 2022, are available on
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2022 Results: May 10, 2022
6 Apr 22
Press Releases
BOSTON, April 6, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish fourth quarter fiscal year 2022 financial results at 6:00 am EDT on Tuesday, May 10, 2022. The
Haemonetics Appoints James D'Arecca Chief Financial Officer
21 Mar 22
Press Releases
BOSTON, March 21, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) today announced that James C. D'Arecca will join the Company as Executive Vice President, Chief Financial Officer, effective April 11, 2022.
Haemonetics to Present at Raymond James 43rd Annual Institutional Investors Conference
23 Feb 22
Press Releases
BOSTON, Feb. 23, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 43rd Annual Institutional